CSVYX
Price
$51.59
Change
-$1.30 (-2.46%)
Updated
Feb 21 closing price
Net Assets
1.67B
DFFVX
Price
$34.10
Change
-$0.82 (-2.35%)
Updated
Feb 21 closing price
Net Assets
13.16B
Ad is loading...

CSVYX vs DFFVX

Header iconCSVYX vs DFFVX Comparison
Open Charts CSVYX vs DFFVXBanner chart's image
Columbia Small Cap Value I Inst3
Price$51.59
Change-$1.30 (-2.46%)
VolumeN/A
Net Assets1.67B
DFA US Targeted Value I
Price$34.10
Change-$0.82 (-2.35%)
VolumeN/A
Net Assets13.16B
CSVYX vs DFFVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSVYX vs. DFFVX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSVYX is a Hold and DFFVX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.2B vs. CSVYX (1.67B). DFFVX pays higher dividends than CSVYX: DFFVX (1.37) vs CSVYX (0.75). CSVYX was incepted earlier than DFFVX: CSVYX (16 years) vs DFFVX (25 years). CSVYX is a more actively managed with annual turnover of: 72.00 vs. DFFVX (20.00). DFFVX has a lower initial minimum investment than CSVYX: DFFVX (0) vs CSVYX (1000000). DFFVX annual gain was more profitable for investors over the last year : 10.28 vs. CSVYX (5.42). DFFVX return over 5 years is better than : 59.88 vs. CSVYX (33.40).
CSVYXDFFVXCSVYX / DFFVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years25 years-
Gain YTD-0.425-0.78654%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.67B13.2B13%
Annual Yield % from dividends0.751.3755%
Returns for 1 year5.4210.2853%
Returns for 3 years7.2920.1936%
Returns for 5 years33.4059.8856%
Returns for 10 years15.9857.9528%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INOD61.917.35
+13.47%
Innodata
VGZ0.630.01
+1.18%
Vista Gold Corp
SYK382.78-3.63
-0.94%
Stryker Corp
ATKR65.78-1.49
-2.21%
Atkore
URGN10.08-0.63
-5.88%
UroGen Pharma Ltd